ZBiotics

ZBiotics is a biotechnology and food/beverage company, based in the United States, founded in 2016. The company's slogan, "Maker of the world's 1st genetically engineered probiotic," encapsulates its mission to utilize genetic engineering for enhancing daily life. Dr. Zack Abbott, a microbiologist, established ZBiotics to explore the potential of genetically engineered probiotics. Their flagship product is a probiotic designed to alleviate the after-effects of alcohol consumption.

Leveraging patented technology, ZBiotics aims to introduce a new category of products that support the body in coping with the challenges of modern life. The company's recent progress includes a significant Series A investment of $22.42M led by Seaside Ventures on March 26, 2024. This investment not only validates the company's potential but also provides essential capital for further research and development. The company's approach to genetic engineering emphasizes transparency, responsibility, and prioritizes the well-being of consumers. This aligns with the growing consumer demand for ethical and beneficial biotechnological advancements.